85 Results for "

siRNA delivery

" in MedChemExpress (MCE) Product Catalog:
Products (85)

85 Results for "siRNA delivery" in MCE Product Catalog:

178
178 Publications Verification
Cat. No.: HY-112251
CAS No.: 1224606-06-7
Purity:  99.68%
Target:  

Liposome

Research Areas:  

Others

D-Lin-MC3-DMA, an ionizable cationic lipid, is a potent siRNA delivery vehicle.
loading...
    loading...
79
79 Cited Publications
Cat. No.: HY-N1446A
CAS No.: 25496-72-4
Glycerol Monoleate is a non-toxic, biodegradable, biocompatible, lipophilic glycerol fatty acid ester. Glycerol Monoleate exhibits hemolytic properties. Glycerol Monoleate is combined with bile salts for use as an emulsifier and absorption enhancer. Glycerol Monoleate can be applied in drug delivery systems and in vitro siRNA delivery .
loading...
    loading...
27
27 Cited Publications
Cat. No.: HY-112764
CAS No.: 160743-62-4
Purity:  98.40%
Target:  

Liposome

Research Areas:  

Metabolic Disease

mPEG2000-DMG is used for the preparation of liposome for siRNA delivery with improved transfection efficiency in vitro. mPEG2000-DMG is also used for the lipid nanoparticle for an oral plasmid DNA delivery approach in vivo through a facile surface modification to improve the mucus permeability and delivery efficiency of the nanoparticles .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-112758
CAS No.: 1190197-97-7
Purity:  99.88%
Target:  

Liposome

Research Areas:  

Others

DLin-KC2-DMA is an ionisable cationic lipid (pKa≈6) that is virtually non-toxic to antigen presenting cells (APCs). DLin-KC2-DMA produces significant siRNA-mediated gene silencing of GAPDH, when binds to lipid nanoparticles (LNP). DLin-KC2-DMA can be used in siRNA delivery studies .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112757
CAS No.: 871258-12-7
Purity:  99.02%
Target:  

Liposome

Research Areas:  

Others

DLinDMA, a ionizable cationic lipid, is a key lipid component of stable nucleic acid lipid particles (SNALPs) as a benchmark. DLinDMA is used for siRNA delivery .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145799
CAS No.: 1857341-90-2
Purity:  95.98%
Target:  

Liposome

Research Areas:  

Cancer

5A2-SC8 is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-168374
CAS No.: 1829524-73-3
DSPE-PEG2000-Mannose is a mannose-containing lipid. DSPE-PEG2000-Mannose is used to prepare mannose-conjugated Liposome (Man-lipo) for siRNA delivery. Mannose-modified liposomes encapsulating IDO siRNA (Man-lipo-siIDO) preferentially knock down IDO expression in the draining lymph nodes and spleens of melanoma-bearing mice. Man-lipo-siIDO delays the onset time of melanoma and reduces tumor volume .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112772A
CAS No.: 917572-74-8
Purity:  ≥98.0%
98N12-5 is a lipid delivery material that assembles to form lipid nanoparticles and mediates the intracellular delivery of siRNA to hepatocytes . 98N12-5 is used in RNA interference-related research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148855
CAS No.: 2383003-60-7
Purity:  ≥98.0%
Target:  

Liposome

Research Areas:  

Others

OF-C4-Deg-Lin is an ionizable lipid with varied linker lengths. OF-C4-Deg-Lin can be used in the generation of lipid nanoparticles (LNPs) for the delivery of siRNA and mRNA .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-145799A
Purity:  98.03%
Target:  

Liposome

Research Areas:  

Cancer

5A2-SC8 TFA is an ionizable amino lipid in lipid nanoparticles (LNPs) that shows high delivery potential and low in vivo toxicity, enabling efficient delivery of small RNAs such as siRNA and miRNA into tumor cells. 5A2-SC8 TFA LNPs can confer a unique delivery fate of RNA within the liver, thereby changing the therapeutic outcomes in cancer models .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P10055A
Synonyms: PSMA-1 TFA
Target:  

PSMA

Research Areas:  

Cancer

PSMA targeting peptide (PSMA-1) TFA is a PSMA-binding peptide that selectively binds to the PSMA receptor on prostate cancer cells and acts as a peptide-based siRNA delivery system by complexing and releasing siRNA. PSMA targeting peptide TFA can be used in research on prostate cancer .
loading...
    loading...
Cat. No.: HY-P5423
CAS No.: 107658-43-5
Target:  

Exosomes Liposome

Research Areas:  

Cancer

GALA is a pH-responsive amphipathic peptide consisting of 30 amino acids, which acts as a lung endothelium-targeting ligand. GALA undergoes a conformational transition from random coil to α-helix in an acidic environment at pH 5.0, thereby inducing endosomal membrane destabilization and fusion. GALA-modified liposomes traverse lung endothelial cells via clathrin-dependent endocytosis and transcytosis, and specifically accumulate in the lungs after intravenous injection. GALA significantly promotes the cytosolic release of cargos carried by exosomes, plasmids and liposomes, effectively enhances gene transfection efficiency, and drives gene knockdown of functional macromolecules (such as siRNA) in alveolar epithelial cells (with no significant cytotoxicity at effective concentrations). GALA serves as a critical tool for studies on lung cancer metastasis (e.g., melanoma lung metastasis) and lung-targeted drug delivery systems .
loading...
    loading...
Cat. No.: HY-156197
CAS No.: 2454045-15-7
Purity:  97.2%
Research Areas:  

Metabolic Disease

Biotin-cholesterol is a biotinylated form of Cholesterol (HY-N0322). Biotin-cholesterol is a liver-targeting ligand (linking cholesterol and biotin via a Gly-Lys dipeptide linker), as well as an enhancer of the component activity of streptavidin-mediated siRNA nanocomplexes. Biotin-cholesterol promotes receptor-mediated endocytosis of the relevant siRNA nanocomplexes, protects siRNA from serum degradation, enables efficient siRNA delivery, and drives target gene silencing. Biotin-cholesterol shows no cytotoxicity in hepatic stellate cells. Biotin-cholesterol can be used in the research of alcoholic liver fibrosis .
loading...
    loading...
Cat. No.: HY-P11070
CAS No.: 1927877-75-5
Target:  

Inhibitory Antibodies

Research Areas:  

Others

SDSSD is an osteoblast-targeting peptide. SDSSD selectively binds to periostin on osteoblasts and mediates targeted delivery to these cells. SDSSD can endow calcium phosphate nanocomposites with bone-targeting properties, and these materials exhibit osteointegrative capacity in both in vitro and in vivo models. When conjugated with polyurethane nanomicelles, SDSSD enables targeted delivery of siRNA/microRNA to osteoblasts .
loading...
    loading...
Cat. No.: HY-168399
CAS No.: 1443687-74-8
Target:  

Liposome

Research Areas:  

Cancer

PEG(2000)-C-DMG is a PEGylated derivative of 1,2-Dimyristoyl-sn-glycerol (HY-128468). PEG(2000)-C-DMG can be used in combination with other lipids in the formation of lipid nanoparticles (LNPs) for the delivery of siRNA .
loading...
    loading...
Cat. No.: HY-147012
CAS No.: 1159408-62-4
Purity:  ≥97.0%
GalNAc-L96 is a conjugate of GalNAc and its ligand L96. When conjugated with the A-rich HCV sequence (H12), GalNAc-L96 binds potently to ASGPR, with a Ki value of 10.4 nM. GalNAc-L96 promotes siRNA delivery to hepatocytes .
loading...
    loading...
Cat. No.: HY-172279A
Target:  

Liposome

Research Areas:  

Cancer

DSPE-PEG2000-TAT is a cell-penetrating peptide-modified PEGylated phospholipid conjugate and cellular uptake enhancer. DSPE-PEG2000-TAT forms via conjugation of Cys-TAT to DSPE-PEG2000-Mal. DSPE-PEG2000-TAT enhances liposomal cellular uptake and siRNA transfection efficiency in glomerular mesangial and macrophage cells. DSPE-PEG2000-TAT can be used for drug delivery .
loading...
    loading...
Cat. No.: HY-173247
CAS No.: 2199491-27-3
GalNAc-NAG37 phosphoramidite is an N-acetylgalactosamine (GalNAc) derivative that acts as a ligand for the asialoglycoprotein receptor (ASGPR). GalNAc-NAG37 phosphoramidite can be used to synthesize GalNAc-siRNA and for oligonucleotide delivery .
loading...
    loading...
Cat. No.: HY-P4086
CAS No.: 1678417-57-6
Target:  

RABV nAChR

Research Areas:  

Neurological Disease Cancer

Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) is a cell-penetrating peptide that is synthesized by adding nona-arginine motif to the carboxy terminus of RVG (rabies virus glycoprotein). Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) binds to
nAChR
on neuronal cells to mediate receptor-mediated endocytosis and targeted siRNA delivery. Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) protects complexed siRNA from degradation, enhances transcellular siRNA delivery in neuronal cells, and promotes efficient, pecific gene silencing. Chimeric Rabies Virus Glycoprotein Fragment (RVG-9R) can be used for the researches of neurological disease and cancer .
loading...
    loading...
Cat. No.: HY-147087
CAS No.: 1318793-78-0
Purity:  ≥98.0%
Target:  

Liposome

Research Areas:  

Cancer

YSK 05 is a pH-sensitive cationic lipid. YSK 05 improves the intracellular trafficking of non-viral vectors. YSK 05-MEND shows significantly good gene silencing activity and hemolytic activity. YSK 05 overcomes the suppression of endosomal escape by PEGylation. YSK 05 effectively enhances siRNA delivery both in vitro and in vivo .
loading...
    loading...